Abstract
The high global incidence of skin, intestinal and breast tumors, combined with the low selectivity, high toxicity and high rates of resistance to chemotherapy drugs currently available highlight the need to identify new antitumor drugs and targets, and develop novel therapeutic strategies that combine efficacy and safety. Nanotechnology can help to fill this gap, since it allows (i) the c…
